Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Murray Korc

Showing results (41-50 of 156) with videos related to

Pageof 16
Sort By:
Cancer Letters|January 18, 2017
Pancreatic cancer: Stroma and its current and emerging targeted therapiesJanaiah Kota, Julie Hancock, Jason Kwon, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 4, 2007
The histone deacetylase inhibitor suberoylanilide hydroxamic acid induces growth inhibition and enhances gemcitabine-induced cell death in pancreatic cancerNichole Boyer Arnold, Nohea Arkus, Jason Gunn, et al.
Biomacromolecules|December 13, 2016
Modular and Adaptable Tumor Niche Prepared from Visible Light Initiated Thiol-Norbornene PhotopolymerizationHan Shih, Tanja Greene, Murray Korc, et al.
Plos One|January 11, 2014
DUSP1 is a novel target for enhancing pancreatic cancer cell sensitivity to gemcitabineFang Liu, A Jesse Gore, Julie L Wilson, et al.
Oncotarget|November 21, 2015
Angiogenic gene signature in human pancreatic cancer correlates with TGF-beta and inflammatory transcriptomesKelly E Craven, Jesse Gore, Julie L Wilson, et al.
Journal of Proteome Research|January 7, 2006
Advances, challenges, and limitations in serum-proteome-based cancer diagnosisMatthias P A Ebert, Murray Korc, Peter Malfertheiner, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 5, 2004
Aberrant expression of neuropilin-1 and -2 in human pancreatic cancer cellsKimi Fukahi, Mitsuharu Fukasawa, Gera Neufeld, et al.
Pancreas|January 7, 2004
Adenovirus-mediated transfer of a truncated fibroblast growth factor (FGF) type I receptor blocks FGF-2 signaling in multiple pancreatic cancer cell linesJörg Kleeff, Nayantara H Kothari, Helmut Friess, et al.
Methods in Molecular Biology (Clifton, N.J.)|January 26, 2008
The application of differential display as a gene profiling toolKen Chien-Neng Chang, Barry Komm, Nichole Bayer Arnold, et al.
Pharmacology & Therapeutics|January 12, 2022
The immune modifying effects of chemotherapy and advances in chemo-immunotherapyDaniel R Principe, Suneel D Kamath, Murray Korc, et al.
Pageof 16

Showing results (41-50 of 156) with videos related to

Sort By:
Pageof 16
Cancer Letters|January 18, 2017
Pancreatic cancer: Stroma and its current and emerging targeted therapiesJanaiah Kota, Julie Hancock, Jason Kwon, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 4, 2007
The histone deacetylase inhibitor suberoylanilide hydroxamic acid induces growth inhibition and enhances gemcitabine-induced cell death in pancreatic cancerNichole Boyer Arnold, Nohea Arkus, Jason Gunn, et al.
Biomacromolecules|December 13, 2016
Modular and Adaptable Tumor Niche Prepared from Visible Light Initiated Thiol-Norbornene PhotopolymerizationHan Shih, Tanja Greene, Murray Korc, et al.
Plos One|January 11, 2014
DUSP1 is a novel target for enhancing pancreatic cancer cell sensitivity to gemcitabineFang Liu, A Jesse Gore, Julie L Wilson, et al.
Oncotarget|November 21, 2015
Angiogenic gene signature in human pancreatic cancer correlates with TGF-beta and inflammatory transcriptomesKelly E Craven, Jesse Gore, Julie L Wilson, et al.
Journal of Proteome Research|January 7, 2006
Advances, challenges, and limitations in serum-proteome-based cancer diagnosisMatthias P A Ebert, Murray Korc, Peter Malfertheiner, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 5, 2004
Aberrant expression of neuropilin-1 and -2 in human pancreatic cancer cellsKimi Fukahi, Mitsuharu Fukasawa, Gera Neufeld, et al.
Pancreas|January 7, 2004
Adenovirus-mediated transfer of a truncated fibroblast growth factor (FGF) type I receptor blocks FGF-2 signaling in multiple pancreatic cancer cell linesJörg Kleeff, Nayantara H Kothari, Helmut Friess, et al.
Methods in Molecular Biology (Clifton, N.J.)|January 26, 2008
The application of differential display as a gene profiling toolKen Chien-Neng Chang, Barry Komm, Nichole Bayer Arnold, et al.
Pharmacology & Therapeutics|January 12, 2022
The immune modifying effects of chemotherapy and advances in chemo-immunotherapyDaniel R Principe, Suneel D Kamath, Murray Korc, et al.
Pageof 16